On November 16, 2024, the Professional Working Group of Standard Samples of Natural Products of the National Technical Committee for Standard Samples organized and convened the preliminary review meeting for the establishment of projects in the first batch of national standard sample development plans of the year in Beijing. The national standard sample, “Standard Sample for the Purity of Cordycepin,” which was led by Fenghuang Pharmaceutical Group (Zhuhai) Co., Ltd. to develop, passed the project establishment review.
The expert panel for this review was composed of a total of 7 experts from Beijing Technology and Business University, the National Institute of Metrology, Chinese Academy of Sciences, the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences, the Beijing Association for Testing Technology of Physical and Chemical Analysis, the Institute of Materia Medica of the Chinese Academy of Medical Sciences, the Institute of Medicinal Plant Development of the Chinese Academy of Medical Sciences, and Beijing Union University. Representatives from 18 applicant units for the research and development plan projects, including Fenghuang Pharmaceutical Group, participated in the meeting.
Cordycepin is a nucleoside analogue isolated from *Cordyceps militaris* and also the first nucleoside antibiotic separated from fungi. Research has confirmed that it is a natural nucleoside antibiotic with the functions of regulating the bodys immunity, antibacterial, anti-inflammatory, antiviral and anti-tumor effects, and is widely used in food, medicine and cosmetics. At present, there is no standard sample for the purity of cordycepin in China. Therefore, the development of a standard sample for the purity of cordycepin is of great significance for unifying standards, optimizing production processes, promoting R&D innovation and ensuring the quality and safety of cordycepin products.
The research team will carry out multiple procedures such as the extraction of cordycepin, the preparation of standard samples, the stability test, the assignment of values to the standard samples, and the acceptance of the standard samples, so as to ensure the standardization of the development process of the standard samples as well as the representativeness and accuracy of the standard samples.
In recent years, Fohow Pharmaceutical Group has actively participated in scientific research, product development, and standard formulation in the field of traditional Chinese medicine, demonstrating the group’s determination and strength in promoting the scientific, practical, and international development of traditional Chinese medicine. In the future, Fohow Pharmaceutical Group will closely follow the pace of the national standardization strategy, deepen exchanges and cooperation with domestic and international standardization organizations, actively explore the formulation of standards in emerging fields, and with a more open attitude and innovative spirit, push the standardization construction to new heights.


